International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, David C. Fajgenbaum, Nikhil C. Munshi et al.|Blood|2018Cited by 421
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman diseaseFrits van Rhee, David C. Fajgenbaum, Éric Oksenhendler et al.|Blood Advances|2020Cited by 218
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registrySheila K. Pierson, David C. Fajgenbaum, Joshua D. Brandstadter et al.|Blood Advances|2025Cited by 19